TFR Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$832K Sell
1,232
-7
-0.6% -$4.16K 0.22% 90
2026
Q2
$621K Buy
1,239
+30
+2% +$14.4K 0.17% 107
2026
Q1
$594K Buy
1,209
+122
+11% +$66.2K 0.18% 98
2025
Q4
$630K Sell
1,087
-11
-1% -$6.22K 0.21% 96
2025
Q3
$533K Sell
1,098
-53
-5% -$24.7K 0.18% 99
2025
Q2
$467K Buy
1,151
+196
+21% +$82K 0.17% 106
2025
Q1
$475K Buy
+955
New +$517K 0.2% 94

Other funds holding TMO

TFR Capital's TMO Position: Q3 2026 in Review

TFR Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.56% in Q3 2026, selling an estimated $4.16K and leaving 1,232 shares worth $832K. The position accounts for 0.22% of the portfolio, ranked #90.

TFR Capital first reported a position in TMO in Q1 2025 and has held it in 7 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • TFR Capital held 1,232 shares of Thermo Fisher Scientific worth $832K as of Q3 2026.
  • TFR Capital sold 7 Thermo Fisher Scientific shares in Q3 2026, an estimated $4.16K.
  • Thermo Fisher Scientific made up 0.22% of TFR Capital's portfolio in Q3 2026, its #90 holding.
  • TFR Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 7 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on TFR Capital's 13F filing for Q3 2026, filed 9 Nov 2026.